Metropolitan Life Insurance CO Royalty Pharma PLC Transaction History

Metropolitan Life Insurance CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jun 21, 2023	BUY	$35.17 - $42.48 $543,587 - $656,570	15,456 New	15,456 $616 Million
Q3 2021 Jun 21, 2023	BUY	$36.14 - $42.24 $561,940 - $656,789	15,549 New	15,549 $562 Million
Q1 2021 Jun 26, 2023	BUY	$42.34 - $52.82 $578,872 - $722,155	13,672 New	13,672 $596 Million
Q4 2020 Jun 22, 2023	BUY	$36.12 - $50.05 $171,244 - $237,287	4,741 New	4,741 $237 Million
Q3 2020 Jun 26, 2023	BUY	$38.56 - $48.36 $146,335 - $183,526	3,795 New	3,795 $160 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.